NPS PHARMACEUTICALS INC
S-3/A, EX-23.1, 2000-11-09
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NPS PHARMACEUTICALS INC, S-3/A, EX-5.1, 2000-11-09
Next: NPS PHARMACEUTICALS INC, S-3/A, EX-23.2, 2000-11-09



<PAGE>

                                                                    EXHIBIT 23.1

              Consent of Independent Certified Public Accountants

The Board of Directors
NPS Pharmaceuticals, Inc.:

We consent to the use of our report incorporated herein by reference and to the
reference to our firm under the headings "Selected Consolidated Financial Data"
and "Experts" in the prospectus.

                                          /s/ KPMG LLP

Salt Lake City, Utah

November 9, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission